Clinical Trial Update: Multimodal Biomarkers for Diagnosis and Prognosis in CAA [Phase 3]

View source ↗

Summary

Phase 3 trial investigating multimodal biomarkers for diagnosis and prognosis in cerebral amyloid angiopathy and related intracranial hemorrhages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cerebral Amyloid Angiopathy
• Intracranial Hemorrhages

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Cerebral Amyloid Angiopathy, Intracranial Hemorrhages | Phase 3 | Status: UNKNOWN